Protokoly_diagnostiki_i_lechenia_zabolevany

: " .

@ :

1." .

2.) " .

3.".

& " 2 " 10 . &

			"		"	21
, % " .		? & "			&
	&$ " 2 &.
" $ " 8-12			# .
& , "						&
				" & &

- & % [3]. % & 3[3]:

1.% % 1 ., " .

2.% % 1

% % % # " & # .

3.	J$ ,					% %
% # " .
1-2						(
%	&		),			% &
. @				3 & "$ ,
$# & .
! [3]:
1.	1-2		–		3-4		\ 1,0-2,0;
2.	3		–		3-4		\ 1,0-2,0 " 12 "

(2 ) 7 + 100 . / " 8 " (3 ) 3-5 .

" & :

1.*6 250 0,5 100

2.*/ V 250 , 500 , 1000

3.*/ V 1000

" & & :

,- ! :

	& " ;
	) % " % ;

% " .

/ , & :

1." , & : . . / . M.J. K " , B.+. @ , '.B. , .6. G . — 2- ., . — 6.: 7 ;?-6>@, 2002. — 1248 .: .

2.Blow-out fractures. EBM Guidelines.25.06.2001 Author: Antti Pihakari. Article ID: ebm00372 (018.104)© 2005 Duodecim Medical Publications Ltd

3.Work Loss Data Institute. Forearm, wrist, and hand. Corpus Christi (TX): Work Loss Data Institute; 2004. 67 p.

* – , # (% % )

"

: 03-030

"$ &: " :

& ! : "$, , , .

' & & : 11

(: S02 " B$" : :

-(S02.1)

-(S02.3)

: + & . ! " - % "

%$# .

: "$, ,

%

"$, % "

_ : &, % % , "

"

: 3

:

?)

% "$:

1.

! " - + "

% "$ ( "

).

2.

-

& % "$. "

$

[

& & [ . + % &

& . + "

"

&

. ! &

"

% "$. ! & .

«! & » -

. + &

.

" & "

. $ " & &

% "$. >[

$

#

%$ & .

3.

% "$ " &

"

%

,

" .

<) &

"

:

1.

:

+

&

%

" V[ % % "$. " & , # , "" . + &, " . B. " %$ $#$ ( [ ) .

') J : %$ [ ,[ , " ( " & " ). < & "$.

- J III: " , %$ "$ % & . ' % " &"$. + & % " . , $# & " & ,& , $ % .

" & :

1. "

2."

3." & &

4.# (6 )

5.# "

6.B

7.6

9.

10.& "

11.7

12._ $

13.HbsAg, Anti-HCV.

" & & :

1.&$ "

4.$

+	:
?) "				% "$:
- " ( "					, % )
&		, & " & %
.
• ' " $					# $" "$&.
• !		& " " $. ' 3				" &
.
- + " & &			%	"$ $ &
" . >				# [ &
,				& : –
"$ " .
• " & & 4-5 .
• 6 % &	[ , &$
& . _						"
" & ,			3 [ & %"$
4-5 .

" " . % :

-6% " % "$ % % " & % .

-' % [ % " , $# "$.

-@ " &" ( [ % % " 6 ).

<) 6 & % : #&$

$" J . > $ & % % & [ ,[ &$ , % , &$ .

') J . J III:

$ " % "$. + & & . L &$ , &$ , , .

% :

- B " " # & " & . B "$& [ #[ , " &$$ .

) , $# :

" " ( , ). + % , % " 3 .

> " , &			" &$, %
" & % .
6 :
- + %$$	%	&	"$
#&$	. '	#	$
	. %$$

$ #&$ " , #.

' " & % % & " 6 . H" ( , $").

% :

- ' V[ % & 3 & , % %. ! " &$ " & .

" & :

1.*6 250 0,5 100

2.*/ V 250 , 500 , 1000

3. */ V 750

4.*7 70% ( )

5.*@ V 1% 1

6.* 0,25

7.*_ 1:5000

8.*7 V 0,18% 1

" & & :

,- ! : , .

/ , & :

1.Fractures of the mandible.EBM Guidelines.29.09.2001. Author: Antti Pihakari. Article ID: ebm00369 (018.013). © 2005 Duodecim Medical Publications Ltd.

2.Facial injuries. .EBM Guidelines.29.09.2001. Author: Antti Pihakari. Article ID: ebm00390 (018.019). © 2005 Duodecim Medical Publications Ltd.

3." , & : . . / . M.J. K " , B.+. @ , '.B. , .6. G . — 2- ., . — 6.: 7 ;?-6>@, 2002. — 1248 .: .

* – , # (% % ) .

8

: 09-126

"$ &: " :

& !: "

' & & ( ): 15

(: C50 ) " " %

) : 8 – 3 " " % .$ : ' # & & "$ $

6 %	$,	TNM
%	$ (2002 .). ! "

& , " (pTNM). & % , % " % .

' " " "-% " % ,% & & ;. !" % , % &

, " & % & " "	.
* : ,	%

, " " % , " 6D,& , & ( , & ), " " , # % ,

" ,		, % ,	&
" % , " / , " % .
"	:
"		: " & , "
%	" " "		%
" . J "
& .

5 : "

" , ? (6					), ?6, & /$ (9
), & , 7 , _ R- , H)B " % ,
, " , , . @ , 6 ;, ; "
% ,		(7 -, 7 +, Her-2-neu),				, !?15-3 %
	.
		: V - " " % , &
	" & &,			(		), &
		(	); V		– " % ,
,			,		%	, %

« & »,		% " % , ,
& " % ,		" / . @ &
&	,		,		"	% ,
	, , .

" & :

2."

3." 3 _

4.! 7

6."

7.# "

8.#

9./ " "

11."

12.B 'BL

13.6

14.	HbsAg, Anti-HCV.

17.1 ( , , , " , " & , )

18."

19.$

20.?J;

21.?!;

22.;

23. -

24.H)B $

25.7

27.H)B " %

28.6

29.@

30.H)B

31.6 ; " %

32.; " %

" & & :

1. &

+ . 6D "$ " &

, , & $"
, &

% / % , " " & . ". @ ( % , " H)B) . ; & (;?<) – "" % " H)B ( ).- " . ; -& " " &$" " . G " ;?< - &/$" & " . &$ - $& " , $" " % " , , .

V & V % . ; % % &" . @ "

	& 400 \ "
7 .
	$# , & 3 .

$# ( 3 : " &% ; & " % ;" % : " &% ; 3 : " %

	" ,
2 )	4 "
" . & 3 6		(	"
% & , " )

4 , % " , & " % , % % " $# . ' "( 40 ) " &$# , %& " , 10-15" & 40 . <) " % " " & . $#6D "$, % , " & & . ! &- && " % , " 3 .

$ $# " % : ) – $, $" &$; ) " 2,5 ;

) % 3 ;

) & " ( , H)B " );

) , " 3( );

) " % "" & ;

%) ; ) " " " ;

) % & & "$ % .

6D – " , " .

" & :

1. *; V 1% 1

2.*š + + +' 25

3.400

4.*@ 200 , 400 ,

5.100 % ; 10 /5 .

6.*? 50 , 100 , 500 .; 5%, 10% 2 , 5 .

7.*$ 5% 400

8.*+ & " " &

9.*B & 150 – 10 \

" & & :

1. *? & 5%, 10%, 20% ;

3. * V & 5 000, 25 000 6>;

2. *B " " , " V 100 6>/,- ! : , & ( )

/ , & :

1.Breast cancer treatment. Institute for Clinical Systems Improvement (ICSI). Breast cancer treatment. Bloomington (VN): Institute for Clinical Systems Improvement (ICSI); 2004 Sep. 41 p. [77 references]

2.Adjuvant Systemik Therapy for Node-negative Breast Cancer. Practic Guideline Report #1-8. Most Recent Literature search: May 1, 2003

3.The role of the Taxanes in the Management of Metastatic Breast cancer. Practic Guideline Report #1-3. April 24, 2004

4.Capecetabine in Stage IY Breast Cancer. Practic Guideline Report #1-16. Version 2, 2003

5.The Role of Aromatase Inhibitors in the Treatment of Postmenopausal Women with Metastatic Breast cancer. Practic Guideline Report #1-11. (Version 2.2002)

6.Practic Guideline Report #1-5. Recommendations modified: October 2003

7.@ & . >% " . 2003, .2, " &5.

* – , # (% % )

: 21-175
"$ &: "
:
&		! :		" ,
		"		( , ),	%
% .
'	& & ( ): 12
(:
T01 , $# &
S21
S31	% , % "
S41			"	"
S51			"&
S61	&
S71
S81
S91
S16	; %
S19	@ "

S19.7	6 %
S19.8	@ "
S19.9	; "

T01.0

T01.1 , % , % " T01.2 & ( ) "

T01.3 & % ( ) "

T01.6 & ( ) % " T01.8 @ " , $# & T01.9 6 % "

) : – % " ,%$# % " [1].

$ : [1,2].

1.	– & ;
2.	– & , 0,5 .;
3.	H – & & ;

4.H – & % , % , " ;

5.! & – % % " % # ;

6.& – & & % .

* : # .

"	: 3
	:

< " ;

	' % % " ;
	"	% " ;
	B " ( , , .);
	&	" ;

	! $# " ( " & ,
.);
	% % ;

" % # .

" & :

1. ;

2.( V % );

3." ( . );

4. " 2- .

5.# ;

6.# " ;

7.;

8.< ;

9.'BL, HbsAg, Anti-HCV.

" & & :

+

+ & .

! " % & "[2].

" :

1." " ;

2.." :

1.	+ % "	;
2.	?	" 3-5 , "

8 " :

% % ;

, $# ;

;

B ;

	% ;
	H .
3.	" % %

	" .
&		,	"	&
		&		-
& % . % & 3			:

1.; % % 1 ., " .

2.; % % 1 % % % # " & # .

3.J$ % % % # ".

1-2 ( % & ), - % & . @

	3 & "$ , $# -&
.
! :
	1-2 – 500 . " 6 " 5-10 per os;